CIK: 0001903793 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $2,686,698 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BETA | BETA Technologies Inc | 16,395,435 | $462,515 | 17.2% | $29.84 | 0.0% | Com Shs Cl A | 086921103 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LFST | LifeStance Health Group Inc | 160,711,618 | $1,131,410 | 42.1% | $10.60 | -43.1% | Com | 53228F101 |
| SION | Sionna Therapeutics Inc | 6,744,962 | $277,488 | 10.3% | $16.34 | +132.1% | Com | 829401108 |
| CBLL | CeriBell Inc. | 3,967,422 | $87,006 | 3.2% | $27.25 | -43.0% | Com | 15678C102 |
| AMRX | Amneal Pharmaceuticals Inc | 12,328,767 | $155,342 | 5.8% | $4.99 | +129.5% | Com Stk Cl A | 03168L105 |
| LTH | Life Time Group Holdings Inc | 17,830,652 | $473,939 | 17.6% | $18.67 | +39.4% | Common Stock | 53190C102 |
| BCAX | Bicara Therapeutics Inc. | 3,010,425 | $50,665 | 1.9% | $25.50 | -33.0% | Com | 055477103 |
| ALLO | Allogene Therapeutics Inc | 18,716,306 | $25,641 | 1.0% | $17.64 | -92.5% | Com | 019770106 |
| — | Rallybio Corp | 3,028,414 | $2,090 | 0.1% | $9.54 | — | Com | 75120L100 |
| TRTX | TPG RE Fin Tr Inc | 2,392,863 | $20,603 | 0.8% | $12.32 | — | Com | 87266M107 |